Dietary Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA) Operate by Different Mechanisms to Modulate Hepatic Steatosis and Hyperinsulemia in <i>fa/fa</i> Zucker Rats

Dietary Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA) Operate by Different Mechanisms to Modulate Hepatic Steatosis and Hyperinsulemia in <i>fa/fa</i> Zucker Rats

Hepatic steatosis, an early stage of non-alcoholic fatty liver disease, is commonly present in obesity and type 2 diabetes, and is associated with reduced hepatic omega-3 polyunsaturated fatty acid (n3-PUFA) status that impacts on the anti-inflammatory and insulin sensitizing functions of n3-PUFA. O...

Full description

Bibliographic Details
Main Authors:	Lena Hong, Peter Zahradka, Luis Cordero-Monroy, Brenda Wright, Carla G. Taylor
Format:	Article
Language:	English
Published:	MDPI AG 2019-04-01
Series:	Nutrients
Subjects:	n3-fatty acids eicosapentaenoic acid docosahexaenoic acid α-linoleic acid hepatic steatosis inflammation <i>fa/fa</i> Zucker rats
Online Access:	https://www.mdpi.com/2072-6643/11/4/917

Similar Items

Effect of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) on the regulation of vascular endothelial cell function
by: Dominika Łacheta, et al.
Published: (2019-10-01)

Differential Effects of Eicosaoentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Neurinal Precursor Cell Proliferation and Neurogenisis

The Effects of High Protein Diets on Metabolic Syndrome Parameters in the fa/fa Zucker Rat
by: Wojcik, Jennifer
Published: (2014)

Pioglitazone is effective for multiple phenotyepes of the Zucker fa/fa rat with polycystc ovary morphology and insulin resistance
by: Miyuki Morishita, et al.
Published: (2018-03-01)

Evaluation of the hepatic bioconversion of α-linolenic acid (ALA) to eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in rats fed with oils from chia (Salvia hispánica) or rosa mosqueta (Rosa rubiginosa)
by: R. Valenzuela B., et al.
Published: (2012-03-01)

Salmon Fillet Intake Led to Higher Serum Triacylglycerol in Obese Zucker Fa/Fa Rats But Not in Normolipidemic Long-Evans Rats
by: Linn Anja Vikøren, et al.
Published: (2018-10-01)

Topical Formulation Comprising Fatty Acid Extract from Cod Liver Oil: Development, Evaluation and Stability Studies
by: Biljana Ilievska, et al.
Published: (2016-06-01)

A Higher Proportion of Eicosapentaenoic Acid (EPA) When Combined with Docosahexaenoic Acid (DHA) in Omega-3 Dietary Supplements Provides Higher Antioxidant Effects in Human Retinal Cells
by: Manuel Saenz de Viteri, et al.
Published: (2020-09-01)

Bioconversion From Docosahexaenoic Acid to Eicosapentaenoic Acid in the Marine Bacterium Shewanella livingstonensis Ac10
by: Takuya Ogawa, et al.
Published: (2020-05-01)

Ozonated Olive Oil Alleviates Hepatic Steatosis in Obese Zucker (fa/fa) Rats
by: Inoue, N., et al.
Published: (2022)

Omega-3 Eicosapentaenoic Acid Is Related to Happiness and a Sense of Fulfillment—A Study among Female Nursing Workers
by: Hirohito Tsuboi, et al.
Published: (2020-11-01)

Importance of EPA and DHA Blood Levels in Brain Structure and Function
by: Clemens von Schacky
Published: (2021-03-01)

Eicosapentaenoic and docosahexaenoic acids attenuate hyperglycemia through the microbiome-gut-organs axis in db/db mice
by: Pan Zhuang, et al.
Published: (2021-09-01)

Retroconversion is a minor contributor to increases in eicosapentaenoic acid following docosahexaenoic acid feeding as determined by compound specific isotope analysis in rat liver
by: Adam H. Metherel, et al.
Published: (2017-11-01)

Evaluation of suppressive and pro-resolving effects of EPA and DHA in human primary monocytes and T-helper cells[S]
by: Anke Jaudszus, et al.
Published: (2013-04-01)

Embryo-toxicity of docosahexaenoic and eicosapentaenoic acids: In vivo and in silico investigations using the chick embryo model
by: Zohreh Salari, et al.
Published: (2021-04-01)

Controlled formation of mono- and dihydroxy-resolvins from EPA and DHA using soybean 15-lipoxygenase[S]
by: Eleanor P. Dobson, et al.
Published: (2013-05-01)

The Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Cardiometabolic Risk Factors: A Systematic Review
by: Jacqueline K. Innes, et al.
Published: (2018-02-01)

Discovery of essential fatty acids
by: Arthur A. Spector, et al.
Published: (2015-01-01)

The ratio of eicosapentaenoic acid to docosahexaenoic acid as a modulator for the cardio-metabolic effects of omega-3 supplements: A meta-regression of randomized clinical trials
by: Suhad AbuMweis, et al.
Published: (2021-03-01)

Regulation of interleukin-2 signaling by fatty acids in human lymphocytes
by: Renata Gorjão, et al.
Published: (2007-09-01)

Effect of eicosapentaenoic acid/docosahexaenoic acid on coronary high-intensity plaques detected with non-contrast T1-weighted imaging (the AQUAMARINE EPA/DHA study): study protocol for a randomized controlled trial
by: Kazuhiro Nakao, et al.
Published: (2018-01-01)

Omega-3 fatty acid supplementation in horses
by: Tanja Hess, et al.
Published: (2014-12-01)

DHA and EPA reverse cystic fibrosis-related FA abnormalities by suppressing FA desaturase expression and activity
by: Sarah W. Njoroge, et al.
Published: (2012-02-01)

Chronic Psychological Stress Was Not Ameliorated by Omega-3 Eicosapentaenoic Acid (EPA)
by: Joanne Bradbury, et al.
Published: (2017-10-01)

Benefits of Structured and Free Monoacylglycerols to Deliver Eicosapentaenoic (EPA) in a Model of Lipid Malabsorption
by: Frédéric Destaillats, et al.
Published: (2012-11-01)

Distinguishing Health Benefits of Eicosapentaenoic and Docosahexaenoic Acids
by: Fraser D. Russell, et al.
Published: (2012-11-01)

Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Uncoupling Protein 3 Gene Expression in C2C12 Muscle Cells
by: Yangha Kim, et al.
Published: (2013-05-01)

TFA and EPA Productivities of Nannochloropsis salina Influenced by Temperature and Nitrate Stimuli in Turbidostatic Controlled Experiments
by: Klaus Heinrich Vanselow, et al.
Published: (2010-09-01)

Docosahexaenoic acid (DHA), essentiality and requirements: why and how to provide supplementation
by: Alfonso Valenzuela, et al.
Published: (2006-06-01)

N-3 Long-Chain Polyunsaturated Fatty Acids, Eicosapentaenoic and Docosahexaenoic Acid, and the Role of Supplementation during Cancer Treatment: A Scoping Review of Current Clinical Evidence
by: Marnie Newell, et al.
Published: (2021-03-01)

The effect of conjugated linoleic acid on arachidonic acid metabolism and eicosanoid production in human saphenous vein endothelial cells.
by: Urquhart, Paula, et al.
Published: (2009)

Long-chain omega-3 fatty acids and the brain: A review of the independent and shared effects of EPA, DPA and DHA
by: Simon eDyall
Published: (2015-04-01)

Eicosahexanoic Acid (EPA) and Docosahexanoic Acid (DHA) in Muscle Damage and Function
by: Eisuke Ochi, et al.
Published: (2018-04-01)

Differential Effects of DHA- and EPA-Rich Oils on Sleep in Healthy Young Adults: A Randomized Controlled Trial
by: Michael J. Patan, et al.
Published: (2021-01-01)

EPA, not DHA, prevents fibrosis in pressure overload-induced heart failure: potential role of free fatty acid receptor 4
by: Julie A. Eclov, et al.
Published: (2015-12-01)

Omega-3 Long-Chain Polyunsaturated Fatty Acids, EPA and DHA: Bridging the Gap between Supply and Demand
by: Douglas R Tocher, et al.
Published: (2019-01-01)

An investigation into the topical and systemic safety and efficacy of a new carbohydrate derived fulvic acid (CHD-FA) product
by: Sabi, Riaz Ahmed
Published: (2013)

Comparison of the Effect of Eicosapentaenoic Acid and Docosahexaenoic Acid on Fasting Blood Sugar, Triglyceride, and Blood Pressure in Type 2 Diabetic Patients
by: Fateme Azizi Soleiman, et al.
Published: (2015-04-01)

Fish Oil Enriched in EPA, but Not in DHA, Reverses the Metabolic Syndrome and Adipocyte Dysfunction Induced by a High-Fat Diet
by: Roberta Dourado Cavalcante da Cunha de Sá, et al.
Published: (2021-02-01)